Massimiliano Sacco

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure.

Journal: Hemoglobin

Published: April 11, 2018

β-Thalassemia heterozygote state detrimentally affects health expectation.

β-Thalassemia heterozygote state detrimentally affects health expectation.

Journal: European journal of internal medicine

Published: January 17, 2018

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.

Journal: European journal of haematology

Published: October 24, 2017

Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures.

Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures.

Journal: Hematology reports

Published: July 05, 2016

Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.

Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.

Journal: European journal of haematology

Published: January 22, 2016

Comparison Between Rapid Intraoperative and Central Laboratory Parathormone Dosage in 12 Kidney Transplant Candidates.

Comparison Between Rapid Intraoperative and Central Laboratory Parathormone Dosage in 12 Kidney Transplant Candidates.

Journal: Transplantation proceedings

Published: December 01, 2015

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.

Journal: Hemoglobin

Published: May 29, 2015

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.

Journal: American journal of hematology

Published: November 20, 2014

Deferiprone versus deferoxamine in sickle cell disease: results from a 5-year long-term Italian multi-center randomized clinical trial.

Deferiprone versus deferoxamine in sickle cell disease: results from a 5-year long-term Italian multi-center randomized clinical trial.

Journal: Blood cells, molecules & diseases

Published: March 18, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026